| 1 | establishment of nucleus localization (GO:0040023) | 9.63267684 |
| 2 | cerebral cortex radially oriented cell migration (GO:0021799) | 8.18536813 |
| 3 | regulation of heat generation (GO:0031650) | 8.09826389 |
| 4 | intracellular lipid transport (GO:0032365) | 7.52339956 |
| 5 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 7.48366630 |
| 6 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 7.36276148 |
| 7 | regulation of NFAT protein import into nucleus (GO:0051532) | 7.33643113 |
| 8 | peripheral nervous system axon ensheathment (GO:0032292) | 7.24997511 |
| 9 | myelination in peripheral nervous system (GO:0022011) | 7.24997511 |
| 10 | nucleoside diphosphate catabolic process (GO:0009134) | 6.82044554 |
| 11 | oxidative phosphorylation (GO:0006119) | 6.28013617 |
| 12 | regulation of actin nucleation (GO:0051125) | 5.90574085 |
| 13 | nucleus localization (GO:0051647) | 5.60887720 |
| 14 | Rac protein signal transduction (GO:0016601) | 5.52439355 |
| 15 | germ cell migration (GO:0008354) | 5.26904835 |
| 16 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.95429587 |
| 17 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.95429587 |
| 18 | histone H3-K36 demethylation (GO:0070544) | 4.80310955 |
| 19 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.77212458 |
| 20 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.66990544 |
| 21 | cerebral cortex cell migration (GO:0021795) | 4.61061508 |
| 22 | microtubule depolymerization (GO:0007019) | 4.59281492 |
| 23 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.54911310 |
| 24 | regulation of transcription from RNA polymerase III promoter (GO:0006359) | 4.53792113 |
| 25 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 4.48144783 |
| 26 | polyol transport (GO:0015791) | 4.34621621 |
| 27 | astrocyte development (GO:0014002) | 4.23973365 |
| 28 | negative regulation of multicellular organism growth (GO:0040015) | 4.23115055 |
| 29 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.19581711 |
| 30 | negative regulation of receptor activity (GO:2000272) | 4.19226561 |
| 31 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 4.14246048 |
| 32 | DNA-dependent DNA replication (GO:0006261) | 4.10145366 |
| 33 | regulation of ARF GTPase activity (GO:0032312) | 4.04245108 |
| 34 | limb bud formation (GO:0060174) | 4.03298672 |
| 35 | head development (GO:0060322) | 4.00828852 |
| 36 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 3.98657871 |
| 37 | osteoblast development (GO:0002076) | 3.97058346 |
| 38 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.89587803 |
| 39 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.86288633 |
| 40 | adaptation of signaling pathway (GO:0023058) | 3.83686040 |
| 41 | temperature homeostasis (GO:0001659) | 3.78119919 |
| 42 | sister chromatid cohesion (GO:0007062) | 3.76648105 |
| 43 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.75521319 |
| 44 | adrenergic receptor signaling pathway (GO:0071875) | 3.74700124 |
| 45 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.71344251 |
| 46 | positive regulation of muscle hypertrophy (GO:0014742) | 3.71344251 |
| 47 | negative regulation of purine nucleotide biosynthetic process (GO:1900372) | 3.69887283 |
| 48 | negative regulation of nucleotide biosynthetic process (GO:0030809) | 3.69887283 |
| 49 | pharyngeal system development (GO:0060037) | 3.67549270 |
| 50 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.57451127 |
| 51 | atrial cardiac muscle cell action potential (GO:0086014) | 3.55126191 |
| 52 | lateral ventricle development (GO:0021670) | 3.44892148 |
| 53 | negative regulation of norepinephrine secretion (GO:0010700) | 3.43937145 |
| 54 | ether lipid metabolic process (GO:0046485) | 3.42751388 |
| 55 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.35658159 |
| 56 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.32802602 |
| 57 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.29881366 |
| 58 | sterol transport (GO:0015918) | 3.18992319 |
| 59 | cholesterol transport (GO:0030301) | 3.18992319 |
| 60 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 3.15489926 |
| 61 | regulation of response to osmotic stress (GO:0047484) | 3.15455961 |
| 62 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.13699866 |
| 63 | mannosylation (GO:0097502) | 3.12668507 |
| 64 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.11423171 |
| 65 | nuclear pore complex assembly (GO:0051292) | 3.10415659 |
| 66 | telencephalon cell migration (GO:0022029) | 3.08537591 |
| 67 | replication fork processing (GO:0031297) | 3.08356774 |
| 68 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 3.08237721 |
| 69 | positive regulation of potassium ion transport (GO:0043268) | 3.07606416 |
| 70 | regulation of protein kinase A signaling (GO:0010738) | 3.06325467 |
| 71 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.04273387 |
| 72 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.03536634 |
| 73 | behavioral response to nicotine (GO:0035095) | 2.99982067 |
| 74 | sphingosine metabolic process (GO:0006670) | 2.98824700 |
| 75 | regulation of mitotic spindle organization (GO:0060236) | 2.98470816 |
| 76 | sympathetic nervous system development (GO:0048485) | 2.97746411 |
| 77 | positive regulation of heart rate (GO:0010460) | 2.91503775 |
| 78 | gene silencing by RNA (GO:0031047) | 2.88957430 |
| 79 | forebrain cell migration (GO:0021885) | 2.86201313 |
| 80 | C-terminal protein amino acid modification (GO:0018410) | 2.85970608 |
| 81 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.84651926 |
| 82 | C-terminal protein lipidation (GO:0006501) | 2.83962759 |
| 83 | diol metabolic process (GO:0034311) | 2.83042331 |
| 84 | microtubule polymerization or depolymerization (GO:0031109) | 2.80517435 |
| 85 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.80378544 |
| 86 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.79317031 |
| 87 | regulation of energy homeostasis (GO:2000505) | 2.73424417 |
| 88 | establishment of protein localization to vacuole (GO:0072666) | 2.71789688 |
| 89 | protein targeting to vacuole (GO:0006623) | 2.71789688 |
| 90 | protein targeting to lysosome (GO:0006622) | 2.71789688 |
| 91 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.71376624 |
| 92 | olfactory bulb development (GO:0021772) | 2.71316306 |
| 93 | autophagic vacuole assembly (GO:0000045) | 2.69545339 |
| 94 | anatomical structure arrangement (GO:0048532) | 2.69364585 |
| 95 | C4-dicarboxylate transport (GO:0015740) | 2.68473652 |
| 96 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.67082513 |
| 97 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.66387069 |
| 98 | protein localization to endosome (GO:0036010) | 15.1529377 |
| 99 | response to nerve growth factor (GO:1990089) | 10.4074343 |
| 100 | cellular response to nerve growth factor stimulus (GO:1990090) | 10.4074343 |
RPL13P4 
